RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies

RBQM Market Leader, CluePoints, Celebrates Milestone of De-risking 1000 Clinical Studies Risk-Based Quality Management: 10 Years of enhancing Quality, Accuracy, and Integrity across all Clinical Trial Data

Creative Enzymes Introduces Two Enzyme Engineering Methods to Accelerate Related Research

Verisense Health Introduces Eminent New Board of Advisors

Verisense® Health, Inc., a digital health software and data management company, today announced the four founding members of its Board of Advisors – Dr. William Crown, Paul Hartung, Dr. Ronald C. Kessler, and Josh Tolkoff. They bring large-scale medical research, statistical, epidemiological, operational and funding expertise to the company.

Kidney and Pancreas Function Diagnostic Enzymes Are Now Available at Creative Enzymes

International Conference on Veterinary Science Medicine and Research

Worldwide veterinarian scientist and researcher are welcome to gather in our reputable conference and sharing the thoughts of experience in the field of the veterinary science medicine and research in Dubai, UAE on DEC 04-05, 2023 and Veterinary Science medicine and research webinar on DEC 11-12, 2023.

DrFirst Acquires Diagnotes Secure Messaging and Care Coordination Platform

DrFirst Acquires Diagnotes Secure Messaging and Care Coordination Platform

NCCHD in Japan Demonstrates Improved Diagnostics Rate for Rare Disease Diagnostics using OmniTier’s CompStor® Genomic Analysis Platform

Benchmark WES re-analysis study by NCCHD, Japan using OmniTier’s AI-based variant interpretation platform achieves around a 42% diagnostics rate, a 7% improvement in the average rate for diagnosing rare diseases

AARDEX and Cambridge Cognition Join Forces to Bring Next-Level Adherence Oversight to Hybrid and Decentralized Clinical Trials

AARDEX and Cambridge Cognition Join Forces to Bring Next-Level Adherence Oversight to Hybrid and Decentralized Clinical Trials Seamless integration of adherence and research data protects participant safety and data quality, with no additional burden for clinical trial sites or participants

Alfa Chemistry Newly Releases Photosensitizers, Photocatalysts, and Quantum Dots

What is Electroplating Intermediate?

Electroplating intermediates refer to a class of fine chemicals used as electroplating additives. Unlike the salt used in the plating production process, the electroplating intermediate is an additive material for electroplating modification in terms of grain size, gloss, thickness, and plating speed.

Creative Biogene Release Fungal ITS Sequencing to Support Microbial Identification

Microbiosci Designs Pseudomonas Fluorescens Fermentation to Support Clinical Research for Several Disease Disorders

Creative Biogene Launches Bioproduction Cell Line Development to Support The Process of Biopharmaceutical Manufacturing

Creative Bioarray Offers More Than 2,000 Tumor Cells from Human and Animals

Creative Bioarray Constructed More Than 6000 Types of High-quality Tissue Microarrays

DDA Platform Accelerates Drug Discovery Process with Wide Range of Assays and Services

MURAL HEALTH AND LEDGER RUN PARTNER TO STREAMLINE CLINICAL BUSINESS OPERATIONS

MURAL HEALTH, a clinical trials technology company that improves the patient and caregiver experience in order to improve enrollment rates, participant retention, and increase protocol compliance and LEDGER RUN, an innovative technology company focused on optimizing clinical operations, today announced a strategic partnership. Through this partnership, Mural Health’s Mural Link™ platform and Ledger Run’s unique ClinRun™ platform work together to improve clinical operations and materially improve the efficiency, and outcomes, of global clinical trials.

Clinion is exhibiting at ISCR Annual Conference being held on 24-25 FEB, 2023 in Delhi

Schedule a Time to Meet us at the Event Book Your Slot Now Clinion is thrilled to be a part of this prestigious conference and looks forward to networking with some of the top minds in the field. We hope

Primary Care partnership launches cognitive impairment case-finding for patients at risk of dementia across Greater Manchester

Linus Health began a partnership with Health Innovation Manchester (HIM) to bring digitalized cognitive screening tools into primary care at four pilot sites. This initiative will empower doctors to identify cognitive impairment early and minimize dementia risks.

Andelyn Biosciences and Odylia Therapeutics Partner to Manufacture Novel Gene Therapy for Vision Loss

Novel AAV Capsid Anc80 enables efficient gene transfer